Clinical Development - read more

Phase I, IIa, IIb/IIIa, IIIb -
A dedicated and proven team will provide:

  • Protocol development
  • Clinical Trial Feasibility
  • Indication experience
  • Coverage
  • Central Study management
  • European central submission services
  • Risk Management Plans
  • On-site Monitoring and centralized Monitoring techniques as well as Risk-based Monitoring approaches
  • Reporting
  • Quick study set-up
  • Innovative patient recruitment support solutions

 

Find out, how AMS  Clinical Research services fit to your needs:

Talk or write to us:

ClinicalResearch bottom

• 2021 – New Literature Search tool launched • 2021 – DIGA dossier submission pioneer • 2021 – NIS-eTMF launched • 2021 – MDR readiness, AMS prepared for Medical Device Trials under new regulation • 2021 – VO (EU) 536/2014, AMS among the first 100 participants in the EMA CTIS Trainer Programme • 2021 – eSignature, AMS introduced DocuSign® • 2017 – Globally unique AMS-ePRO® features • 2016 – CRO of the year award •

News